Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2017

01-08-2017 | Gastrointestinal Oncology

Incidence and Prognostic Value of Metastases to “Posterior” and Para-aortic Lymph Nodes in Resectable Gastric Cancer

Authors: Daniele Marrelli, MD, Francesco Ferrara, MD, Simone Giacopuzzi, MD, Paolo Morgagni, MD, Alberto Di Leo, MD, Lorenzo De Franco, MD, Corrado Pedrazzani, MD, Luca Saragoni, MD, Giovanni De Manzoni, MD, Franco Roviello, MD, FACS

Published in: Annals of Surgical Oncology | Issue 8/2017

Login to get access

Abstract

Background

The purpose of this retrospective study was to evaluate the incidence and prognostic value of metastases to “posterior” (8p, 12b/p, 13) and para-aortic lymph nodes in a large cohort of Western patients submitted to D2 plus lymphadenectomy.

Methods

Removal of “posterior” nodes was performed in 743 patients, and para-aortic lymphadenectomy in a subgroup of 390 patients. After lymph node mapping and retrieval on the fresh specimen, a median number of 41 total lymph nodes were analyzed. The median follow-up period was 37 months for the entire series and 68 months for survivors.

Results

Of 743 included patients, 23 (3.1%) had metastases in station 8p, 12 (1.6%) in station 12b/p, and 19 (2.6%) in station 13. On the whole, 47 of 743 patients (6.3%) had positive “posterior” nodes. Para-aortic metastases were present in 42 of 390 patients (10.8%). Metastases to “posterior” stations were significantly related to depth of invasion, number of positive nodes, and surgical radicality. Distal tumors showed higher trend to metastasize to “posterior” nodes than upper third, whereas for para-aortic metastases it was the reverse. 5-year survival in patients with positivity to “posterior” nodes was 17%, with no significant difference according to 8p, 12b/p, and 13 stations; long-term outcome was overlapping to pN3b stage. 5-year survival in para-aortic positive cases was 11%, and a trend to better outcome was observed in proximal tumors.

Conclusions

Although metastases to “posterior” and para-aortic nodes are expression of an advanced nodal stage, not negligible survival rates are observed in subgroups of patients.
Literature
1.
go back to reference Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 2012;30:3834–40.CrossRefPubMed Han DS, Suh YS, Kong SH, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 2012;30:3834–40.CrossRefPubMed
2.
go back to reference Marrelli D, Morgagni P, de Manzoni G, et al. External validation of a score predictive of recurrence after radical surgery for non-cardia gastric cancer: results of a follow-up study. J Am Coll Surg. 2015;221:280–90.CrossRefPubMed Marrelli D, Morgagni P, de Manzoni G, et al. External validation of a score predictive of recurrence after radical surgery for non-cardia gastric cancer: results of a follow-up study. J Am Coll Surg. 2015;221:280–90.CrossRefPubMed
3.
go back to reference Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.CrossRefPubMed Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908–14.CrossRefPubMed
4.
go back to reference Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522–30.CrossRefPubMedPubMedCentral Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999;79:1522–30.CrossRefPubMedPubMedCentral
5.
go back to reference Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.CrossRefPubMed Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.CrossRefPubMed
6.
go back to reference de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ. Quality control of lymph node dissection in the Dutch gastric cancer trial. Br J Surg. 2015;102:1388–93.CrossRefPubMed de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ. Quality control of lymph node dissection in the Dutch gastric cancer trial. Br J Surg. 2015;102:1388–93.CrossRefPubMed
7.
go back to reference Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309–15.CrossRefPubMed Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309–15.CrossRefPubMed
8.
go back to reference Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101:23–31.CrossRefPubMed Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101:23–31.CrossRefPubMed
9.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef
10.
go back to reference Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–49.CrossRefPubMed Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–49.CrossRefPubMed
11.
go back to reference Lee JH, Kim JG, Jung HK, et al. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014;14:87–104. Lee JH, Kim JG, Jung HK, et al. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014;14:87–104.
12.
go back to reference De Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20:20–30.CrossRefPubMed De Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20:20–30.CrossRefPubMed
13.
go back to reference Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.CrossRefPubMed Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.CrossRefPubMed
14.
go back to reference Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Aikou S, Yamaguchi T. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes? Ann Surg Oncol. 2010;17:2031–6.CrossRefPubMed Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Aikou S, Yamaguchi T. Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes? Ann Surg Oncol. 2010;17:2031–6.CrossRefPubMed
15.
go back to reference Roviello F, Pedrazzani C, Marrelli D, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439–46.CrossRefPubMed Roviello F, Pedrazzani C, Marrelli D, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36:439–46.CrossRefPubMed
16.
go back to reference Hasegawa S, Yoshikawa T, Rino Y, et al. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol. 2013;20:4252–9.CrossRefPubMed Hasegawa S, Yoshikawa T, Rino Y, et al. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol. 2013;20:4252–9.CrossRefPubMed
17.
go back to reference Eom BW, Joo J, Kim YW, et al. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer? Ann Surg Oncol. 2013;20:2669–75.CrossRefPubMed Eom BW, Joo J, Kim YW, et al. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer? Ann Surg Oncol. 2013;20:2669–75.CrossRefPubMed
18.
go back to reference Kodera Y, Kobayashi D, Tanaka C, Fujiwara M. Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer? Surg Today. 2015;45(9):1082–90.CrossRefPubMed Kodera Y, Kobayashi D, Tanaka C, Fujiwara M. Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer? Surg Today. 2015;45(9):1082–90.CrossRefPubMed
19.
go back to reference Morita S, Fukagawa T, Fujiwara H, Katai H. The clinical significance of para-aortic nodal dissection for advanced gastric cancer. Eur J Surg Oncol. 2016;42:1448–54.CrossRefPubMed Morita S, Fukagawa T, Fujiwara H, Katai H. The clinical significance of para-aortic nodal dissection for advanced gastric cancer. Eur J Surg Oncol. 2016;42:1448–54.CrossRefPubMed
20.
go back to reference Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol. 2007;14:25–33.CrossRefPubMed Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol. 2007;14:25–33.CrossRefPubMed
21.
go back to reference Marrelli D, Mazzei MA, Pedrazzani C, et al. High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol. 2011;18:2265–72.CrossRefPubMed Marrelli D, Mazzei MA, Pedrazzani C, et al. High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol. 2011;18:2265–72.CrossRefPubMed
22.
go back to reference Di Leo A, Marrelli D, Roviello F, et al. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-53.CrossRefPubMed Di Leo A, Marrelli D, Roviello F, et al. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-53.CrossRefPubMed
23.
go back to reference Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602.CrossRefPubMed Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, de Manzoni G. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol. 2009;16:594-602.CrossRefPubMed
24.
go back to reference Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255:486–91. Marrelli D, Morgagni P, de Manzoni G, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255:486–91.
25.
go back to reference Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed
26.
go back to reference Lee SL, Lee HH, Ko YH, Song KY, Park CH, Jeon HM, Kim SS. Relevance of hepatoduodenal ligament lymph nodes in resectional surgery for gastric cancer. Br J Surg. 2014;101:518–22.CrossRefPubMed Lee SL, Lee HH, Ko YH, Song KY, Park CH, Jeon HM, Kim SS. Relevance of hepatoduodenal ligament lymph nodes in resectional surgery for gastric cancer. Br J Surg. 2014;101:518–22.CrossRefPubMed
27.
go back to reference Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, Stomach Cancer Study Group of the Japan Clinical Oncology Group. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653–60.CrossRefPubMed Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, Stomach Cancer Study Group of the Japan Clinical Oncology Group. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653–60.CrossRefPubMed
28.
go back to reference Xue L, Chen XL, Zhang WH, et al. Risk factors and prognostic significance of retropancreatic lymph nodes in gastric adenocarcinoma. Gastroenterol Res Pract. 2015;2015:367679.CrossRefPubMedPubMedCentral Xue L, Chen XL, Zhang WH, et al. Risk factors and prognostic significance of retropancreatic lymph nodes in gastric adenocarcinoma. Gastroenterol Res Pract. 2015;2015:367679.CrossRefPubMedPubMedCentral
29.
go back to reference Shen DF, Chen DW, Quan ZW, et al. Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma. World J Gastroenterol. 2008;14:936–8.CrossRefPubMedPubMedCentral Shen DF, Chen DW, Quan ZW, et al. Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma. World J Gastroenterol. 2008;14:936–8.CrossRefPubMedPubMedCentral
30.
go back to reference Wei ZW, Xia GK, Wu Y, Schwarz RE, Smith DD, He YL, Zhang CH. Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysis. Hepatogastroenterology. 2013;60:1789-96.PubMed Wei ZW, Xia GK, Wu Y, Schwarz RE, Smith DD, He YL, Zhang CH. Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysis. Hepatogastroenterology. 2013;60:1789-96.PubMed
31.
go back to reference Imamura T, Komatsu S, Ichikawa D, et al. Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer. World J Gastroenterol. 2015;21:10866-73.CrossRefPubMedPubMedCentral Imamura T, Komatsu S, Ichikawa D, et al. Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer. World J Gastroenterol. 2015;21:10866-73.CrossRefPubMedPubMedCentral
32.
go back to reference Tokunaga M, Ohyama S, Hiki N, et al. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241–6.CrossRefPubMed Tokunaga M, Ohyama S, Hiki N, et al. Therapeutic value of lymph node dissection in advanced gastric cancer with macroscopic duodenum invasion: is the posterior pancreatic head lymph node dissection beneficial? Ann Surg Oncol. 2009;16:1241–6.CrossRefPubMed
33.
go back to reference de Manzoni G, Di Leo A, Roviello F, Marrelli D, Giacopuzzi S, Minicozzi AM, Verlato G. Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer. Ann Surg Oncol. 2011;18:2273–80.CrossRefPubMed de Manzoni G, Di Leo A, Roviello F, Marrelli D, Giacopuzzi S, Minicozzi AM, Verlato G. Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric cancer. Ann Surg Oncol. 2011;18:2273–80.CrossRefPubMed
34.
go back to reference Junfeng Z, Yingxue H, Peiwu Y. Systematic review of risk factors for metastasis to para-aortic lymph nodes in gastric cancer. Surg Oncol. 2013;22:210–6.CrossRefPubMed Junfeng Z, Yingxue H, Peiwu Y. Systematic review of risk factors for metastasis to para-aortic lymph nodes in gastric cancer. Surg Oncol. 2013;22:210–6.CrossRefPubMed
35.
go back to reference de Manzoni G, Verlato G, Bencivenga M, et al. Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. Eur J Surg Oncol. 2015;41:534–40.CrossRefPubMed de Manzoni G, Verlato G, Bencivenga M, et al. Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. Eur J Surg Oncol. 2015;41:534–40.CrossRefPubMed
36.
go back to reference Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol. 2015;21:7954–69.CrossRefPubMedPubMedCentral Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol. 2015;21:7954–69.CrossRefPubMedPubMedCentral
37.
go back to reference Marrelli D, Pedrazzani C, Morgagni P, et al; Italian Research Group for Gastric Cancer. Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011;98:1273–83.CrossRefPubMed Marrelli D, Pedrazzani C, Morgagni P, et al; Italian Research Group for Gastric Cancer. Changing clinical and pathological features of gastric cancer over time. Br J Surg. 2011;98:1273–83.CrossRefPubMed
Metadata
Title
Incidence and Prognostic Value of Metastases to “Posterior” and Para-aortic Lymph Nodes in Resectable Gastric Cancer
Authors
Daniele Marrelli, MD
Francesco Ferrara, MD
Simone Giacopuzzi, MD
Paolo Morgagni, MD
Alberto Di Leo, MD
Lorenzo De Franco, MD
Corrado Pedrazzani, MD
Luca Saragoni, MD
Giovanni De Manzoni, MD
Franco Roviello, MD, FACS
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5857-8

Other articles of this Issue 8/2017

Annals of Surgical Oncology 8/2017 Go to the issue